Healthcare Business
Latest News
Variable Long COVID Definitions Create Hurdles in Care, Research
There is a need to consolidate various long COVID definitions to establish a standardized definition that ensures consistent recognition, documentatio...
Deciding When to Treat Patients With Alopecia Areata
Panelists discuss how the decision to treat vs observe alopecia areata (AA) depends on factors such as disease severity, patient symptoms, and the use...
Hope on the Horizon for Underserved Patients With Multiple Myeloma: Joseph Mikhael, MD
Explore the disparities in multiple myeloma treatment and how new initiatives aim to improve clinical trial participation among underrepresented patie...
Tricuspid Regurgitation Reliable Prognostic Indicator of PAH Severity
Despite knowledge of the benefits of right heart hemodynamic measures for evaluating patient prognosis in the setting of pulmonary arterial hypertensi...
Assessment of Variation in Ambulatory Cardiac Monitoring Among Commercially Insured Patients
Ambulatory cardiac monitors’ clinical and economic outcomes vary; one long-term continuous monitor brand showed greater arrhythmia diagnosis, fewer re...
Greater NACT Use at High-Volume Centers Linked to Lower Surgical Mortality, Longer Survival in Advanced Ovarian Cancer
High-volume cancer centers utilizing neoadjuvant chemotherapy (NACT) significantly reduce surgical mortality and enhance survival rates in patients wi...
CEPHEUS Trial Data Reinforce DVRd as New Standard for Multiple Myeloma: Saad Z. Usmani, MD, MBA
Continuing his interview about these results, CEPHEUS lead investigator Saad Z. Usmani, MD, MBA, FACP, FASCO, highlights the minimal residual disease...
Choosing an Initial Therapy for Alopecia Areata
Panelists discuss how key factors such as disease severity, patient preference, and payer requirements influence the choice of initial therapy for alo...
Genetics, Comorbidities Associated With Cardiomyopathy and Atrial Fibrillation
The cause of dilated cardiomyopathy (DCM) can be associated with the presence of the TTN gene combined with preexisting comorbidities like atrial fibr...
QRISK3 Tool Predicts Thrombotic Events in ET, PV
The QRISK3 assessment is designed for the general population, but it appears to also have utility in patients with essential thrombosis and polycythem...
Variable Long COVID Definitions Create Hurdles in Care, Research
Deciding When to Treat Patients With Alopecia Areata
Hope on the Horizon for Underserved Patients With Multiple Myeloma: Joseph Mikhael, MD
Tricuspid Regurgitation Reliable Prognostic Indicator of PAH Severity
Assessment of Variation in Ambulatory Cardiac Monitoring Among Commercially Insured Patients
Greater NACT Use at High-Volume Centers Linked to Lower Surgical Mortality, Longer Survival in Advanced Ovarian Cancer
CEPHEUS Trial Data Reinforce DVRd as New Standard for Multiple Myeloma: Saad Z. Usmani, MD, MBA
Choosing an Initial Therapy for Alopecia Areata
Genetics, Comorbidities Associated With Cardiomyopathy and Atrial Fibrillation
QRISK3 Tool Predicts Thrombotic Events in ET, PV
Advertisement
300x250 Banner
Recent Content
COPD Biologics: Early Treatment Insights
Pulmonology • 2 hours ago
Antihypertensive Medication Guidelines
Cardiology • 4 hours ago
Juvenile Arthritis Care Transition
Rheumatology • 6 hours ago